Evidence map›Paper›PMID 34469789›Full record

ArticleActa biomaterialia2021

Direct comparison of angiogenesis in natural and synthetic biomaterials reveals that matrix porosity regulates endothelial cell invasion speed and sprout diameter.

William Y Wang, Robert N Kent, Stephanie A Huang, Evan H Jarman, Eve H Shikanov, Christopher D Davidson, Harrison L Hiraki, Daphne Lin, Monica A Wall, Daniel L Matera and 4 more

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Augmented 3D Printing for Multiscale Microphysiological Systems.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  10. Review
  11. Article
  12. Article
  13. Microenvironmental determinants of endothelial cell heterogeneity.Nature reviews. Molecular cell biology · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

William Y WangDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, United States.
Robert N KentDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, United States.
Stephanie A HuangJoint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC 27514, United States.
Evan H JarmanDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, United States.
Eve H ShikanovDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, United States.
Christopher D DavidsonDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, United States.
Harrison L HirakiDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, United States.
Daphne LinDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, United States.
Monica A WallDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, United States.
Daniel L MateraDepartment of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, United States.
Jae-Won ShinDepartment of Pharmacology and Regenerative Medicine & Department of Bioengineering, University of Illinois at Chicago, Chicago, IL, 60607, United States.
William J PolacheckJoint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC 27514, United States; McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27514, United States.
Ariella ShikanovDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, United States; Department of Macromolecular Science & Engineering, University of Michigan, Ann Arbor, MI, 48109, United States; Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, 48109, United States.
Brendon M BakerDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, United States; Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, United States. Electronic address: bambren@umich.edu.
University of Michigan · USUniversity of North Carolina at Chapel Hill · USUniversity of Illinois Chicago · US

Funding

MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
Pre-doctoral Training Program in Integrative Vascular BiologyT32HL069768 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Christopher P. Mack · 2002 to 2026
$9.7M
Encapsulation of mesenchymal stromal cells in engineered microgels for resolution of lung fibrosisR01HL141255 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHIN, JAE-WON · 2019 to 2023
$2.0M
Engineering microscale hydrogel deposition to direct single stem cell differentiationR01GM141147 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHIN, JAE-WON · 2021 to 2024
$1.9M
Angiogenic hydrogel composites for microvascular integration of organoid graftsR01EB030474 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BAKER, BRENDON M · 2021 to 2024
$1.4M
Mechanics of fibrosis in 3D biomimetic extracellular matricesR00HL124322 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BAKER, BRENDON M · 2017 to 2019
$747k
Mechanics of fibrosis in 3D biomimetic extracellular matricesK99HL124322 · NHLBI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI BAKER, BRENDON M · 2015 to 2016
$261k
Fiber-reinforced hydrogels to guide the formation and integration of engineered microvasculatureF31HL152501 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DAVIDSON, CHRISTOPHER DURBIN · 2020 to 2021
$53k
NHLBI NIH HHS F31 HL152501NHLBI NIH HHS K99 HL124322NHLBI NIH HHS R00 HL124322NHLBI NIH HHS R01 HL141255NHLBI NIH HHS T32 HL069768NIBIB NIH HHS R01 EB030474NIGMS NIH HHS R01 GM141147NIGMS NIH HHS T32 GM007863
6 · The paper itself

Abstract

Vascularization of large, diffusion-hindered biomaterial implants requires an understanding of how extracellular matrix (ECM) properties regulate angiogenesis. Sundry biomaterials assessed across many disparate angiogenesis assays have highlighted ECM determinants that influence this complex multicellular process. However, the abundance of material platforms, each with unique parameters to model endothelial cell (EC) sprouting presents additional challenges of interpretation and comparison between studies. In this work we directly compared the angiogenic potential of commonly utilized natural (collagen and fibrin) and synthetic dextran vinyl sulfone (DexVS) hydrogels in a multiplexed angiogenesis-on-a-chip platform. Modulating matrix density of collagen and fibrin hydrogels confirmed prior findings that increases in matrix density correspond to increased EC invasion as connected, multicellular sprouts, but with decreased invasion speeds. Angiogenesis in synthetic DexVS hydrogels, however, resulted in fewer multicellular sprouts. Characterizing hydrogel Young's modulus and permeability (a measure of matrix porosity), we identified matrix permeability to significantly correlate with EC invasion depth and sprout diameter. Although microporous collagen and fibrin hydrogels produced lumenized sprouts in vitro, they rapidly resorbed post-implantation into the murine epididymal fat pad. In contrast, DexVS hydrogels proved comparatively stable. To enhance angiogenesis within DexVS hydrogels, we incorporated sacrificial microgels to generate cell-scale pores throughout the hydrogel. Microporous DexVS hydrogels resulted in lumenized sprouts in vitro and enhanced cell invasion in vivo. Towards the design of vascularized biomaterials for long-term regenerative therapies, this work suggests that synthetic biomaterials offer improved size and shape control following implantation and that tuning matrix porosity may better support host angiogenesis. STATEMENT OF SIGNIFICANCE: Understanding how extracellular matrix properties govern angiogenesis will inform biomaterial design for engineering vascularized implantable grafts. Here, we utilized a multiplexed angiogenesis-on-a-chip platform to compare the angiogenic potential of natural (collagen and fibrin) and synthetic dextran vinyl sulfone (DexVS) hydrogels. Characterization of matrix properties and sprout morphometrics across these materials points to matrix porosity as a critical regulator of sprout invasion speed and diameter, supported by the observation that nanoporous DexVS hydrogels yielded endothelial cell sprouts that were not perfusable. To enhance angiogenesis into synthetic hydrogels, we incorporated sacrificial microgels to generate microporosity. We find that microporosity increased sprout diameter in vitro and cell invasion in vivo. This work establishes a composite materials approach to enhance the vascularization of synthetic hydrogels.

Indexed as

Biocompatible MaterialsNeovascularization, PhysiologicAnimalsEndothelial CellsExtracellular MatrixHydrogelsMicePorosityBiocompatible MaterialsHydrogelsAngiogenesisCell migrationCell proliferationChemotaxisECMEndothelial cellsHydrogelsMatrix porosityMicrofluidicsMicrovasculatureSprouting Morphogenesis

Identifiers

PMID34469789
PMCPMC8595798
OpenAlexW3197983014

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.